![Oxiris Crrt Set Usage: It Is Intended For Patients In Need Of Blood Purification, Price 70000 INR/Kit | ID: 7022334 Oxiris Crrt Set Usage: It Is Intended For Patients In Need Of Blood Purification, Price 70000 INR/Kit | ID: 7022334](https://tiimg.tistatic.com/fp/1/007/022/oxiris-crrt-set-334-w300.jpg)
Oxiris Crrt Set Usage: It Is Intended For Patients In Need Of Blood Purification, Price 70000 INR/Kit | ID: 7022334
![The future of continuous renal replacement therapy - See - 2021 - Seminars in Dialysis - Wiley Online Library The future of continuous renal replacement therapy - See - 2021 - Seminars in Dialysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c8612dbe-6a2f-456d-81cc-e686e17af7d2/sdi12961-fig-0002-m.jpg)
The future of continuous renal replacement therapy - See - 2021 - Seminars in Dialysis - Wiley Online Library
![FDA OKs Baxter's Oxiris Blood Purification Filter For COVID-19 Treatment - Medical Product Outsourcing FDA OKs Baxter's Oxiris Blood Purification Filter For COVID-19 Treatment - Medical Product Outsourcing](https://dev.rodpub.com/images/210/468_main.jpg)
FDA OKs Baxter's Oxiris Blood Purification Filter For COVID-19 Treatment - Medical Product Outsourcing
![Baxter International on Twitter: "Learn more about a new study published in @CritCareMed showing blood purification with our Oxiris filter set can play a role in the management of severely ill #COVID19 Baxter International on Twitter: "Learn more about a new study published in @CritCareMed showing blood purification with our Oxiris filter set can play a role in the management of severely ill #COVID19](https://pbs.twimg.com/media/ElVqxl2WkAAJJnw.jpg)
Baxter International on Twitter: "Learn more about a new study published in @CritCareMed showing blood purification with our Oxiris filter set can play a role in the management of severely ill #COVID19
![Baxter India gets CDSCO approval for use of its Oxiris filter to treat COVID-19 patients | Health Tips and News Baxter India gets CDSCO approval for use of its Oxiris filter to treat COVID-19 patients | Health Tips and News](https://imgk.timesnownews.com/story/filter_1.gif?tr=w-1200,h-900)
Baxter India gets CDSCO approval for use of its Oxiris filter to treat COVID-19 patients | Health Tips and News
![Baxter TPE 2000 CRRT Set, For Haemodialysis, Rs 22000.00 /piece Vahini Healthcare Private Limited | ID: 23496275997 Baxter TPE 2000 CRRT Set, For Haemodialysis, Rs 22000.00 /piece Vahini Healthcare Private Limited | ID: 23496275997](https://5.imimg.com/data5/SELLER/Default/2021/5/YD/OE/SA/29401541/tpe-2000-500x500.png)
Baxter TPE 2000 CRRT Set, For Haemodialysis, Rs 22000.00 /piece Vahini Healthcare Private Limited | ID: 23496275997
![References in Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study - Journal of Hepatology References in Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c7d5f6d9-f9ac-43bf-901b-5d8cd973bf19/fx1_lrg.jpg)
References in Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study - Journal of Hepatology
![MedSurgSolutions MSS - Medical Solutions Company in Lebanon, KSA, UAE, Bahrain, Qatar, Oman and Kuwait - Med Surg Solutions MedSurgSolutions MSS - Medical Solutions Company in Lebanon, KSA, UAE, Bahrain, Qatar, Oman and Kuwait - Med Surg Solutions](http://www.medsurgsolutions.com/upload/products/thumbs700/188.jpg)
MedSurgSolutions MSS - Medical Solutions Company in Lebanon, KSA, UAE, Bahrain, Qatar, Oman and Kuwait - Med Surg Solutions
![Extracorporeal Filter and Circuit Patency: A Personalized Approach to Anticoagulation | SpringerLink Extracorporeal Filter and Circuit Patency: A Personalized Approach to Anticoagulation | SpringerLink](https://media.springernature.com/original/springer-static/image/chp%3A10.1007%2F978-3-030-37323-8_28/MediaObjects/488522_1_En_28_Fig2_HTML.png)